Impact of Dialysis Dependence on Survival for Multiple Myeloma Patients with Renal Impairment: A Multicenter Retrospective Study in China

被引：1
|
作者：
Jian, Yuan [1 ]
Zhou, Huixing [2 ]
Xie, Weiwei [3 ]
Ren, Yuan [4 ]
Zhang, Zhiyao [1 ]
Yang, Guangzhong [1 ]
Geng, Chuanying [1 ]
Jia, Jing [1 ]
Chen, Wenming [2 ]
Li, Jian [5 ]
Huang, Wenrong [6 ]
Cen, Xinan [3 ]
Gao, Wen [2 ]
机构：
[1] Capital Med Univ, Beijing Chao Yang Hosp, Dept Hematol, Beijing, Peoples R China
[2] Capital Med Univ, Beijing Chaoyang Hosp, Beijing, Peoples R China
[3] Peking Univ First Hosp, Beijing, Peoples R China
[4] Gen Hosp Peoples Liberat Army, Med Cctr 1, Dept Hematol, Beijing, Peoples R China
[5] Chinese Acad Med Sci & Peking Union Med Coll, Peking Union Med Coll Hosp, Dept Hematol, Beijing, Peoples R China
[6] Chinese Peoples Liberat Army Gen Hosp, Med Ctr 5, Beijing, Peoples R China
来源：
BLOOD | 2022年 / 140卷
关键词：
D O I：
10.1182/blood-2022-159950
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：12635 / 12636
页数：2
相关论文
共 50 条
  • [31] Hematogenous Extramedullary Relapse in Multiple Myeloma - A Multicenter Retrospective Study in 127 Patients
    Avivi, Irit
    Cohen, Yael C.
    Mikala, Gabor
    Garderet, Laurent
    Gueye, Mor Seny
    Jayabalan, David S.
    Glickman, Sophia
    Niesvizky, Ruben
    Gozzetti, Alessandro
    Wisniewska-Piaty, Katarzyna
    Waszczuk-Gajda, Anna
    Usnarska-Zubkiewicz, Lidia
    Hus, Iwona
    Kazmierczak, Renata Guzicka
    Radocha, Jakub
    Milunovic, Vibor
    Davila, Julio
    Gentile, Massimo
    Suska, Anna
    Goldman-Mazur, Sarah
    Castillo, Jorge J.
    Jurczyszyn, Artur
    BLOOD, 2018, 132
  • [32] A multicenter retrospective study of 223 patients with t(14;16) in multiple myeloma
    Goldman-Mazur, Sarah
    Jurczyszyn, Artur
    Castillo, Jorge J.
    Waszczuk-Gajda, Anna
    Grzasko, Norbert
    Radocha, Jakub
    Bittrich, Max
    Kortuem, K. Martin
    Gozzetti, Alessandro
    Usnarska-Zubkiewicz, Lidia
    Davila Valls, Julio
    Jayabalan, David S.
    Niesvizky, Ruben
    Kelman, Julia
    Coriu, Daniel
    Rosinol, Laura
    Szukalski, Lukasz
    Gonzalez-Calle, Veronica
    Mateos, Maria V.
    Jamroziak, Krzysztof
    Hus, Iwona
    Avivi, Irit
    Cohen, Yael
    Suska, Anna
    Chappell, Aimee
    Madduri, Deepu
    Chhabra, Saurabh
    Kleman, Ariel
    Hari, Parameswaran
    Delforge, Michel
    Robak, Pawel
    Gentile, Massimo
    Kozlowska, Izabela
    Goldberg, Stuart L.
    Czepiel, Jacek
    Silbermann, Rebecca
    Olszewski, Adam J.
    Barth, Peter
    Mikala, Gabor
    Chim, Chor S.
    Dlugosz-Danecka, Monika
    Grosicki, Sebastian
    Vesole, David H.
    AMERICAN JOURNAL OF HEMATOLOGY, 2020, 95 (05) : 503 - 509
  • [33] Safety and efficacy of bortezomib-based regimens for multiple myeloma patients with renal impairment: a retrospective study of Italian Myeloma Network GIMEMA
    Morabito, Fortunato
    Gentile, Massimo
    Ciolli, Stefania
    Petrucci, Maria T.
    Galimberti, Sara
    Mele, Giuseppe
    Casulli, Antonio F.
    Mannina, Donato
    Piro, Eugenio
    Pinotti, Graziella
    Palmieri, Salvatore
    Catalano, Lucio
    Callea, Vincenzo
    Offidani, Massimo
    Musto, Pellegrino
    Bringhen, Sara
    Baldini, Luca
    Tosi, Patrizia
    Di Raimondo, Francesco
    Boccadoro, Mario
    Palumbo, Antonio
    Cavo, Michele
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2010, 84 (03) : 223 - 228
  • [34] Outcome of multiple myeloma patients with renal failure: A retrospective study.
    Naik, Ramavath Devendra
    Kumar, Lalit
    Mittal, Abhenil
    Gupta, Vineet Govinda
    Patekar, Mukesh
    Malik, Prabhat Singh
    Kumar, Santosh
    Singh, Vishwajeet
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [35] EFFECTS OF BORTEZOMIB ON RENAL IMPAIRMENT MULTIPLE MYELOMA PATIENTS
    Chen, W.
    Lu, J.
    Hou, J.
    HAEMATOLOGICA, 2013, 98 : 340 - 341
  • [36] Optimizing the Treatment of Patients With Multiple Myeloma and Renal Impairment
    Grzasko, Norbert
    Morawska, Marta
    Hus, Marek
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2015, 15 (04): : 187 - 198
  • [37] Comparison of renal impairment in multiple myeloma patients treated with zoledronic acid or ibandronate:: A retrospective review
    Antràs, L
    Smith, M
    Neary, M
    Green, J
    Wintfeld, N
    Duh, MS
    BONE, 2006, 38 (03) : S87 - S87
  • [38] Activity and Safety of Lenalidomide and Dexamethasone in Multiple Myeloma Patients with Advanced Renal Failure: a Spanish Multicenter Retrospective Study.
    Roig, Monica
    Ibanez, Angela
    Garcia, Inmaculada
    Vera, Juan A.
    Aguilar, Carlos
    del Campo, Raquel
    Gonzalez, Nicolas
    Martinez, Rafael
    Palomera, Luis
    Picon, Isabel
    Rodriguez, Jose N.
    Sanz, Miguel A.
    de la Rubia, Javier
    BLOOD, 2009, 114 (22) : 749 - 749
  • [39] Survival of Multiple Myeloma Patients in the Era of Novel Agents and Autologous Stem Cell Transplantation: A Multicenter Retrospective Collaborative Study of the Japanese Society of Myeloma
    Ozaki, Shuji
    Handa, Hiroshi
    Saitoh, Takayuki
    Murakami, Hirokazu
    Itagaki, Mitsuhiro
    Asaoku, Hideki
    Suzuki, Kenshi
    Isoda, Atsushi
    Sawamura, Morio
    Konishi, Jun
    Sunami, Kazutaka
    Takezako, Naoki
    Hagiwara, Shotaro
    Kuroda, Yoshiaki
    Chou, Takaaki
    Shibata, Eiko
    Shimizu, Kazuyuki
    Nagura, Eiichi
    BLOOD, 2014, 124 (21)
  • [40] Severe renal impairment as an adverse prognostic factor for survival in newly diagnosed multiple myeloma patients
    Chen, Xuduan
    Luo, Xiaofeng
    Zu, Yanping
    Issa, Hajji Ally
    Li, Linlin
    Ye, Hong
    Yang, Ting
    Hu, Jianda
    Wei, Lixin
    JOURNAL OF CLINICAL LABORATORY ANALYSIS, 2020, 34 (09)
12345